$NWRN #Newron Pharmaceuticals SpA Newron Pharmaceuticals - Sarizotan fails to shine: On 4 May Newron Pharmaceuticals announced that the pivotal Rett syndrome STARS study of sarizotan had not met the primary or any secondary endpoints. The… https://t.co/YSjsEWKXDN #equity #stocks https://t.co/mYTSXC5nzE